Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Clinical trials have demonstrated an impressive average weight reduction of 15 to 20 percent with lifestyle changesan effectiveness hard to surpass
Slight differences in meal composition, hydration, injection timing, and injection-site reactions can change whether symptoms resolve or linger
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): A randomized, placebo-controlled, phase 3 extension study
Supplementary information Supplementary Tables 15 (download XLSX Supplementary Table 1 Baseline demographics and clinical characteristics of the patients in the SELECT trial
95% CI, 1.26-1.56), but shorter duration (=26 weeks) of treatment was not (RR 0.79)
US$ 26.82
US$ 24.81
US$ 27.39
